GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ACGL · Dec 31, 2023

ARCH CAPITAL GROUP LTD.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000947484-24-000020Insurance
Cash80thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$917.0M · CORE · VALID

Policy-benefit growth65thOwn-history percentile · N=20
Evidence method

Yoy · gp.insurance.policy_benefits

24.24% · OPTIONAL · VALID

Net-income growth85thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

200.83% · CORE · VALID

Premium growth90thOwn-history percentile · N=20
Evidence method

Yoy · gp.insurance.premiums

28.54% · CORE · VALID

Revenue growth85thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

41.80% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History43 statesSelf-history eligible
Period transition

What moved in the state?

Cash Increased
Previous
$859.0M
Current
$917.0M
Delta
$58.0M
Claims Growth Increased
Previous
-2.12%
Current
24.24%
Delta
26.36%
Earnings Growth Decreased
Previous
4127.82%
Current
200.83%
Delta
-3927.00%
Premium Growth Decreased
Previous
31.46%
Current
28.54%
Delta
-2.92%
Revenue Growth Increased
Previous
39.51%
Current
41.80%
Delta
2.29%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.